CE-MS in biomarker discovery, validation, and clinical application

Proteomics - Clinical Applications

Volumn 5, Issue 1-2, 2011, Pages 9-23

  Mischak, Harald ^a,b   Schanstra, Joost P ^c,d  

^a MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c INSERM   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Biomarker; CE; MS; Peptides; Urine

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN FIBER; CREATININE; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; AGING; ANCA ASSOCIATED VASCULITIS; CAPILLARY ELECTROPHORESIS; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY POLYCYSTIC DISEASE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROFLUIDICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE HYPERTROPHY; PROTEOMICS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE; URINALYSIS; VALIDATION PROCESS;

AGING; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; ELECTROPHORESIS, CAPILLARY; HUMANS; KIDNEY DISEASES; MASS SPECTROMETRY; PROTEOMICS;

EID: 79251560313     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000058     Document Type: Review

References (84)

1. Jensen, P. K., Pasa-Tolic, L., Anderson, G. A., Horner, J. A. et al., Probing proteomes using capillary isoelectric focusing-electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 1999, 71, 2076-2084.
2. Kasicka, V., Recent developments in CE and CEC of peptides. Electrophoresis 2008, 29, 179-206.
3. Dolnik, V., Capillary electrophoresis of proteins 2005-2007. Electrophoresis 2008, 29, 143-156.
4. Kasicka, V., Recent advances in CE and CEC of peptides (2007-2009). Electrophoresis 2010, 31, 122-146.
5. El Rassi, Z., Electrophoretic and electrochromatographic separation of proteins in capillaries: an update covering 2007-2009. Electrophoresis 2010, 31, 174-191.
6. Simo, C., Elvira, C., Gonzalez, N., San Roman, J. et al., Capillary electrophoresis-mass spectrometry of basic proteins using a new physically adsorbed polymer coating. Some applications in food analysis. Electrophoresis 2004, 25, 2056-2064.
7. Ullsten, S., Zuberovic, A., Wetterhall, M., Hardenborg, E. et al., A polyamine coating for enhanced capillary electrophoresis-electrospray ionization-mass spectrometry of proteins and peptides. Electrophoresis 2004, 25, 2090-2099.
8. Erny, G. L., Elvira, C., San, R. J., Cifuentes, A., Capillary electrophoresis using copolymers of different composition as physical coatings: a comparative study. Electrophoresis 2006, 27, 1041-1049.
9. Garza, S., Chang, S., Moini, M., Simplifying capillary electrophoresis-mass spectrometry operation: eliminating capillary derivatization by using self-coating background electrolytes. J. Chromatogr. A 2007, 1159, 14-21.
10. Gaspar, A., Englmann, M., Fekete, A., Harir, M., Schmitt-Kopplin, P., Trends in CE-MS 2005-2006. Electrophoresis 2008, 29, 66-79.
11. Elhamili, A., Wetterhall, M., Sjodin, M., Sebastiano, R., Bergquist, J., Analysis of peptides using N-methylpolyvinylpyridium as silica surface modifier for CE-ESI-MS. Electrophoresis 2010, 31, 1151-1156.
12. Lucy, C. A., MacDonald, A. M., Gulcev, M. D., Non-covalent capillary coatings for protein separations in capillary electrophoresis. J. Chromatogr. A 2008, 1184, 81-105.
13. Mischak, H., Coon, J. J., Novak, J., Weissinger, E. M. et al., Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass Spectrom. Rev. 2009, 28, 703-724.
14. Stutz, H., Advances in the analysis of proteins and peptides by capillary electrophoresis with matrix-assisted laser desorption/ionization and electrospray-mass spectrometry detection. Electrophoresis 2005, 26, 1254-1290.
15. Amon, S., Plematl, A., Rizzi, A., Capillary zone electrophoresis of glycopeptides under controlled electroosmotic flow conditions coupled to electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 2006, 27, 1209-1219.
16. Zürbig, P., Renfrow, M. B., Schiffer, E., Novak, J. et al., Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 2006, 27, 2111-2125.
17. Zamfir, A. D., Recent advances in sheathless interfacing of capillary electrophoresis and electrospray ionization mass spectrometry. J. Chromatogr. A 2007, 1159, 2-13.
18. Tempels, F. W., Underberg, W. J., Somsen, G. W., de Jong, G. J., On-line coupling of SPE and CE-MS for peptide analysis. Electrophoresis 2007, 28, 1319-1326.
19. Haselberg, R., de Jong, G. J., Somsen, G. W., Capillary electrophoresis-mass spectrometry for the analysis of intact proteins. J. Chromatogr. A 2007, 1159, 81-109.
20. Hernandez-Borges, J., Borges-Miquel, T. M., Rodriguez-Delgado, M. A., Cifuentes, A., Sample treatments prior to capillary electrophoresis-mass spectrometry. J. Chromatogr. A 2007, 1153, 214-226.
21. Klampfl, C. W., CE with MS detection: a rapidly developing hyphenated technique. Electrophoresis 2009, 30, S83-S91.
22. Piaggio, M. V., Peirotti, M. B., Deiber, J. A., Exploring the evaluation of net charge, hydrodynamic size and shape of peptides through experimental electrophoretic mobilities obtained from CZE. Electrophoresis 2006, 27, 4631-4647.
23. Williams, B. J., Russell, W. K., Russell, D. H., Utility of CE-MS data in protein identification. Anal. Chem. 2007, 79, 3850-3855.
24. Kolch, W., Neususs, C., Pelzing, M., Mischak, H., Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005, 24, 959-977.
25. Schiffer, E., Mischak, H., Novak, J., High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 2006, 6, 5615-5627.
26. Mischak, H., Kolch, W., Aivalotis, M., Bouyssie, D. et al., Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin. Appl. 2010, 4, 464-478.
27. Song, E. J., Babar, S. M., Oh, E., Hasan, M. N. et al., CE at the omics level: towards systems biology - an update. Electrophoresis 2008, 29, 129-142.
28. Bakry, R., Huck, C. W., Najam-ul-Haq, M., Rainer, M., Bonn, G. K., Recent advances in capillary electrophoresis for biomarker discovery. J. Sep. Sci. 2007, 30, 192-201.
29. Simpson, S. L., Jr., Quirino, J. P., Terabe, S., On-line sample preconcentration in capillary electrophoresis. Fundamentals and applications. J. Chromatogr. A 2008, 1184, 504-541.
30. Peng, Y., Pallandre, A., Tran, N. T., Taverna, M., Recent innovations in protein separation on microchips by electrophoretic methods. Electrophoresis 2008, 29, 157-178.
31. Fritzsche, S., Hoffmann, P., Belder, D., Chip electrophoresis with mass spectrometric detection in record speed. Lab. Chip 2010, 10, 1227-1230.
32. Schaub, S., Wilkins, J., Weiler, T., Sangster, K. et al., Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65, 323-332.
33. Theodorescu, D., Wittke, S., Ross, M. M., Walden, M. et al., Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006, 7, 230-240.
34. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G. et al., Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J. Proteome Res. 2009, 8, 268-281.
35. Weissinger, E. M., Wittke, S., Kaiser, T., Haller, H. et al., Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004, 65, 2426-2434.
36. Decramer, S., Gonzalez de, P. A., Breuil, B., Mischak, H. et al., Urine in clinical proteomics. Mol. Cell. Proteomics 2008, 7, 1850-1862.
37. Theodorescu, D., Fliser, D., Wittke, S., Mischak, H. et al., Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 2005, 26, 2797-2808.
38. Frommberger, M., Zürbig, P., Jantos, J., Krahn, T. et al., Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry. Proteomics Clin. Appl. 2007, 1, 650-660.
39. Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F. et al., CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin. Appl. 2008, 2, 964-973.
40. Rejtar, T., Hu, P., Juhasz, P., Campbell, J. M. et al., Off-line coupling of high-resolution capillary electrophoresis to MALDI-TOF and TOF/TOF MS. J. Proteome Res. 2002, 1, 171-179.
41. Matthiesen, R., Methods, algorithms and tools in computational proteomics: a practical point of view. Proteomics 2007, 7, 2815-2832.
42. Dakna, M., He, Z., Yu, W. C., Mischak, H., Kolch, W., Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 1250-1258.
43. Righetti, P. G., Campostrini, N., Pascali, J., Hamdan, M., Astner, H., Quantitative proteomics: a review of different methodologies. Eur. J. Mass Spectrom. 2004, 10, 335-348.
44. Zybailov, B., Coleman, M. K., Florens, L., Washburn, M. P., Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 2005, 77, 6218-6224.
45. DeKeyser, S. S., Li, L., Matrix-assisted laser desorption/ionization Fourier transform mass spectrometry quantitation via in cell combination. Analyst 2006, 131, 281-290.
46. Abdi, H. Bonferroni and Sidak Corrections for Multiple Comparisons, Sage, Thousand Oaks, CA 2007.
47. Westfall, P. H., Young, S. S., Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment, Wiley, New York 1993.
48. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. B (Methodological) 1995, 57, 125-133.
49. Mischak, H., Allmaier, G., Apweiler, R., Attwood, T. et al., Recommendations for biomarker identification and qualification in clinical proteomics. Sci. Transl. Med. 2010, 2, 46ps42.
50. Good, D. M., Zurbig, P., Argiles, A., Bauer, H. W. et al., Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell. Proteomics 2010, Epub ahead of print.
51. Mischak, H., Rossing, P., Proteomic Biomarkers in diabetic nephropathy - reality or future promise? Nephrol. Dial. Transplant. 2010, 25, 2843-2845.
52. Rossing, P., The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 2005, 48, 1439-1444.
53. Rossing, K., Mischak, H., Dakna, M., Zürbig, P. et al., Urinary proteomics in diabetes and CKD. J. Am. Soc. Nephrol. 2008, 19, 1283-1290.
54. Snell-Bergeon, J. K., Maahs, D. M., Ogden, L. G., Kinney, G. L. et al., Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol. Ther. 2009, 11, 1-9.
55. Haubitz, M., Good, D. M., Woywodt, A., Haller, H. et al., Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in ANCA associated vasculitis. Mol. Cell. Proteomics 2009, 8, 2296-2307.
56. Kistler, A. D., Mischak, H., Poster, D., Dakna, M. et al., Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009, 76, 89-96.
57. Glassock, R. J., Debate: CON Position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Am. J. Nephrol. 2010, 31, 462-465.
58. Decramer, S., Wittke, S., Mischak, H., Zürbig, P. et al., Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 2006, 12, 398-400.
59. Decramer, S., Bascands, J. L., Schanstra, J. P., Non-invasive markers of ureteropelvic junction obstruction. World J. Urol. 2007, 25, 457-465.
60. Drube, J., Zurbig, P., Schiffer, E., Lau, E. et al., Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr. Nephrol. 2010, 25, 1673-1678.
61. Drube, J., Schiffer, E., Mischak, H., Kemper, M. J. et al., Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol. Dial. Transplant. 2009, 24, 2161-2169.
62. Metzger, J., Kirsch, T., Schiffer, E., Ulger, P. et al., Diagnostic marker pattern of sequenced urinary peptides for early and accurate detection of acute kidney injury. Kidney Int. 2010, in press.
63. Simionato, A. V., Carrilho, E., Maggi Tavares, M. F., CE-MS and related techniques as a valuable tool in tumor biomarkers research. Electrophoresis 2010, 31, 1214-1226.
64. Schiffer, E., Vlahou, A., Petrolekas, A., Stravodimos, K. et al., Prediction of muscle-invasive bladder cancer using urinary proteomics. Clin. Cancer Res. 2009, 15, 4935-4943.
65. Theodorescu, D., Schiffer, E., Bauer, H. W., Douwes, F. et al., Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin. Appl. 2008, 2, 556-570.
66. Kaiser, T., Kamal, H., Rank, A., Kolb, H. J. et al., Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004, 104, 340-349.
67. Weissinger, E. M., Hertenstein, B., Mischak, H., Ganser, A., Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis. Expert. Rev. Proteomics 2005, 2, 639-647.
68. Weissinger, E. M., Schiffer, E., Hertenstein, B., Ferrara, J. L. et al., Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 2007, 109, 5511-5519.
69. Fazzini, P. F., Prati, P. L., Rovelli, F., Antoniucci, D. et al., Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am. J. Cardiol. 1993, 72, 1383-1388.
70. Scognamiglio, R., Negut, C., Ramondo, A., Tiengo, A., Avogaro, A., Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2006, 47, 65-71.
71. Zimmerli, L. U., Schiffer, E., Zürbig, P., Kellmann, M. et al., Urinary proteomics biomarkers in coronary artery disease. Mol. Cell. Proteomics 2008, 7, 290-298.
72. von Zur Muhlen, C., Schiffer, E., Zuerbig, P., Kellmann, M. et al., Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J. Proteome Res. 2009, 8, 335-345.
73. Delles, C., Schiffer, E., von Zur Muhlen, C., Peter, K. et al., Urinary proteomic diagnosis of coronary artery disease: identification and clilnical validation in 623 subjects. J. Hypertens. 2010, in press.
74. Maahs, D. M., Siwy, J., Argiles, A., Cerna, M. et al., Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology. PLoS ONE 2010, in press.
75. Zürbig, P., Decramer, S., Dakna, M., Jantos, J. et al., The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 2009, 9, 2108-2117.
76. Comper, W. D., Osicka, T. M., Clark, M., MacIsaac, R. J., Jerums, G., Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int. 2004, 65, 1850-1855.
77. Haubitz, M., Wittke, S., Weissinger, E. M., Walden, M. et al., Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005, 67, 2313-2320.
78. Haubitz, M., Fliser, D., Rupprecht, H., Floege, J. et al., Defining renal diseases based on proteom analysis. Nephrol. Dial Transplant. 2005, 20, V20.
79. Fliser, D., Novak, J., Thongboonkerd, V., Argiles, A. et al., Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18, 1057-1071.
80. Rossing, K., Mischak, H., Dakna, M., Zurbig, P. et al., Proteomic discovery and validation of urinary biomarkers for diabetes and chronis renal disease. J. Am. Soc. Nephrol. 2008, 19, 1283-1290
81. Merchant, M. L., Perkins, B. A., Boratyn, G. M., Ficociello, L. H. et al., Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J. Am. Soc. Nephrol. 2009, 20, 2065-2074.
82. Rossing, K., Mischak, H., Rossing, P., Schanstra, J. P. et al., The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics Clin. Appl. 2008, 2, 997-1007.
83. Schena, F. P., Gesualdo, L., Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 2005, 16, S30-S33.
84. Vlahou, A., Allmaier, G., Attwood, T., Bongcam-Rudloff, E. et al., 2nd combined working group and management committee meeting of urine and kidney proteomics COST action. Proteomics Clin. Appl. 2009, 3, 1017-1022.